Performance of glycated hemoglobin A1c for the diagnosis of gestational diabetes mellitus during the SARS-CoV-2 pandemic in Belgium (2020-2021).
OBJECTIVES: During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, health care access was restricted. To reduce the risk of maternal SARS-CoV-2 infection, simplified screening recommendations for gestational diabetes mellitus (GDM) have been suggested, leading to glycated hemoglobin A1c (HbA1c) being proposed as an alternative to the oral glucose tolerance test (OGTT). This study aimed to assess the optimal HbA1c cutoff to confirm GDM diagnosis according to IADPSG/WHO2013 guidelines. METHODS: In this retrospective study, 3361 pregnancies were followed at the hospital... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2023 |
Verlag/Hrsg.: |
Elsevier Scientific Publishers
|
Schlagwörter: | Pregnancy / Female / Humans / Diabetes / Gestational / Glycated Hemoglobin / SARS-CoV-2 / Retrospective Studies / Belgium / Pandemics / COVID-19 / Blood Glucose / COVID-19 Testing / Epidemiology / Gestational diabetes mellitus / HbA1c / IADPSG/WHO criteria |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26965123 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/283129 |